CLINICAL_TRIALS
trial_result
· 2024-05-03
Clinical Trial Update: A Study to Evaluate XTR006 in Chinese Volunteers [Phase 1]
Summary
Phase 1 study evaluating XTR006 in Chinese volunteers with Alzheimer's disease has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sinotau Pharmaceutical Group | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED